ArticleBMC public health2025

Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV: a cohort study.

Shahin Soltani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.